TITLE

In Human Monocyte Derived Dendritic Cells SOCS1 Interacting with CYTIP Induces the Degradation of CYTIP by the Proteasome

AUTHOR(S)
Grabher, Daniela; Hofer, Susanne; Ortner, Daniela; Heufler, Christine
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
CYTIP (cytohesin interacting protein) is an intracellular molecule induced in dendritic cells during maturation. CYTIP modulates the binding intensity of the adhesion molecule LFA-1. If dendritic cells are silenced for CYTIP they keep longer contacts with T-cells resulting in a lower T cell stimulation. We identified Suppressor of cytokine signaling-1 (SOCS-1) as a binding partner for CYTIP in human monocyte derived dendritic cells. In Western blot analyses we found that CYTIP expression is down regulated at later time points, starting at about 72 hours after induction of maturation. To investigate a possible role for SOCS-1 in taking CYTIP to the degradation machinery of the cell we measured endogenous CYTIP protein levels in mature dendritic cells transfected with SOCS-1 encoding plasmid in quantitative Western blot analyses. We observed lower amounts of endogenous CYTIP in mature dendritic cells transfected with SOCS-1 encoding plasmid compared with untransfected dendritic cells. Experiments with the proteasome-inhibitor Bortezomib/Velcade® show stable CYTIP expression levels in dendritic cells. In addition, we show that CYTIP in dendritic cells matured for 48 hours is ubiquitinated and thus ready for degradation. We here describe a newly identified binding partner of CYTIP, SOCS-1, and confirm its function in regulating the degradation of CYTIP by the proteasome.
ACCESSION #
87625524

 

Related Articles

  • Comparison of two different protocols for the induction of maturation of human dendritic cells in vitro. Colic, Miodrag; Mojsilovic, Slavko; Pavlovic, Bojan; Vucicevic, Dragana; Majstorovic, Ivana; Bufan, Biljana; Stojic-Vukanic, Zorica; Vasilijic, Sasa; Vucevic, Dragana; Gasic, Sonja; Balint, Bela // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Sep/Oct2004, Vol. 61 Issue 5, p471 

    Background. Dendritic cells (DC) have been used for immunotherapy of malignant tumors, different kinds of infections, and other clinical conditions. For that purpose, optimal conditions for the generation of functionally mature DC in vitro are required. Two different protocols for the induction...

  • Ah, but Which Proteasome?  // BioWorld Today;7/1/2013, Vol. 24 Issue 125, p1 

    The article reports on the findings by researchers from Duke University and Merck Research Laboratories that dendritic cells responded more strongly to tumor cells when the dendritic cells were modified to express the same form of the proteasome used by tumor cells.

  • Dendritic Cell Endothelium Interaction in Autoimmunity. Weis, M.; Schlichting, C. L.; Schareck, W. D. // Current Pharmaceutical Design;Jan2004, Vol. 10 Issue 2, p171 

    Monocyte derived dendritic cells play a central role in controlling immunity by activating naïve T lymphocytes. Monocytes can leave the blood stream by endothelial cell transmigration and differentiation into dendritic cells. A fundamental aspect of dendritic cell biology is their capacity to...

  • Corrigendum.  // Immunology & Cell Biology;Oct2002, Vol. 80 Issue 5, p507 

    Presents a corrected reprint of the article 'Flt3 ligand expands dendritic cell numbers in normal and malignant murine prostate,' by M. Moghaddami, B. Swart et al, published in the 2002 issue of the periodical 'Immunology and Cell Biology.'

  • Dendritic cells spill the beans. Watts, Colin // Nature Cell Biology;Oct99, Vol. 1 Issue 6, pE152 

    Antigens taken up into cells by endocytosis are not usually presented on class I MHC molecules to cytotoxic T cells. But there are good reasons to allow professional antigen-presenting cells to do this, and it seems that dendritic cells of the immune system have an efficient mechanism in place...

  • Different mechanisms are involved in apoptosis induced by melanoma gangliosides on human monocyte-derived dendritic cells. Karim Bennaceur; Iuliana Popa; Jessica Alice Chapman; Camille Migdal; Josette Péguet-Navarro; Jean-Louis Touraine; Jacques Portoukalian // Glycobiology;Jun2009, Vol. 19 Issue 6, p576 

    Tumor escape is linked to multiple mechanisms, notably the liberation, by tumor cells, of soluble factors that inhibit the function of dendritic cells (DC). We have shown that melanoma gangliosides impair DC differentiation and induce their apoptosis. The present study was aimed to give insight...

  • Gene expression profiling of human monocyte-derived dendritic cells -- searching for molecular regulators of tolerogenicity. Schinnerling, Katina; García-González, Paulina; Aguillón, Juan Carlos // Frontiers in Immunology;Oct2015, Vol. 6, p1 

    The ability of dendritic cells (DCs) to initiate and modulate antigen-specific immune responses has made them attractive targets for immunotherapy. Since DC research in humans is limited by the scarcity of DC populations in the blood circulation, most of our knowledge about DC biology and...

  • Extracellular adenine nucleotides inhibit the release of major monocyte recruiters by human monocyte-derived dendritic cells Horckmans, Michael; Marcet, Brice; Marteau, Frédéric; Bulté, Frédéric; Maho, Arielle; Parmentier, Marc; Boeynaems, Jean-Marie; Communi, Didier // FEBS Letters;Feb2006, Vol. 580 Issue 3, p747 

    Abstract: Extracellular ATP is known to affect the maturation of monocyte-derived dendritic cells mainly by regulation of cytokines and costimulatory molecules. The present study describes the inhibition of MCP-1 (CCL2) and MIP-1α (CCL3) release by human monocyte-derived dendritic cells in...

  • Immunotherapy of NOD Mice With Bone Marrow-Derived Dendritic Cells. Feili-Hariri, Maryam; Xin Dong; Alber, Sean M.; Watkins, Simon C.; Salter, Russell D.; Morel, Penelope A. // Diabetes;Dec99, Vol. 48 Issue 12, p2300 

    Evaluates bone marrow-derived dendritic cell (DC) populations from NOD mice, the murine model for type I human diabetes. Phenotype of purified DC populations; In vivo migration of DC populations; Differences in the phenotype, T-cell stimulatory capacity, and the antigen uptake of two DC...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics